Literature DB >> 23291220

Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.

Momoko Oka1, Shunji Hasegawa2, Takeshi Matsushige2, Hirofumi Inoue2, Madoka Kajimoto2, Naoko Ishikawa3, Hiroshi Isumi3, Takashi Ichiyama2.   

Abstract

BACKGROUND: Acute disseminated encephalomyelitis (ADEM) is clinically characterized by the acute onset of neurological symptoms after a viral infection or immunization, and is thought to represent an autoimmune disease directed against myelin. Tau protein is a phosphorylated microtubule-associated protein, primarily located in neuronal axons. Increased levels of tau protein in cerebrospinal fluid (CSF) are found in various pathological conditions.
METHODS: We used tau protein as a marker of axonal damage and examined its concentration in the CSF of 27 children with ADEM.
RESULTS: CSF tau protein concentration in children with ADEM was significantly higher than that in the CSF of control subjects (P=0.008). There were no significant differences in CSF tau protein concentrations in the ADEM patients with and without encephalopathy. The CSF tau protein concentration in patients with partial lesion resolution in follow-up brain MRI was significantly higher than in patients with complete lesion resolution (P=0.014).
CONCLUSIONS: In conclusion, we demonstrated that CSF tau protein concentration was significantly increased in ADEM patients. Our findings suggest that axonal damage may occur in addition to demyelination in children with ADEM.
Copyright © 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute disseminated encephalomyelitis; Axonal damage; Tau protein

Mesh:

Substances:

Year:  2013        PMID: 23291220     DOI: 10.1016/j.braindev.2012.11.013

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  6 in total

1.  Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism.

Authors:  Francesca Rosini; Alessandra Rufa; Lucia Monti; Letizia Tirelli; Antonio Federico
Journal:  J Neurol       Date:  2014-10-31       Impact factor: 4.849

2.  Antisense reduction of tau in adult mice protects against seizures.

Authors:  Sarah L DeVos; Dustin K Goncharoff; Guo Chen; Carey S Kebodeaux; Kaoru Yamada; Floy R Stewart; Dorothy R Schuler; Susan E Maloney; David F Wozniak; Frank Rigo; C Frank Bennett; John R Cirrito; David M Holtzman; Timothy M Miller
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

3.  Assessment of the tau protein concentration in patients with tick-borne encephalitis.

Authors:  Piotr Czupryna; Barbara Mroczko; Sławomir Pancewicz; Paweł Muszynski; Sambor Grygorczuk; Justyna Dunaj; Karol Borawski; Magdalena Róg-Makal; Renata Świerzbińska; Joanna Zajkowska; Maciej Kondrusik; Anna Moniuszko-Malinowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-05       Impact factor: 3.267

Review 4.  A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children.

Authors:  Susanna Esposito; Giada Maria Di Pietro; Barbara Madini; Maria Vincenza Mastrolia; Donato Rigante
Journal:  Autoimmun Rev       Date:  2015-06-14       Impact factor: 9.754

Review 5.  Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders.

Authors:  Caterina Allegretta; Emanuele D'Amico; Virginia Manuti; Carlo Avolio; Massimo Conese
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

6.  Controlled fluorescence quenching by antibody-conjugated graphene oxide to measure tau protein.

Authors:  Ao Huang; Luning Zhang; Weiwei Li; Zeyu Ma; Shi Shuo; Tianming Yao
Journal:  R Soc Open Sci       Date:  2018-04-11       Impact factor: 2.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.